Diaceutics PLC

We’d like to wish each of our valued clients, stakeholders and lab partners a very Happy Thanksgiving filled with joy and happiness from everyone at Diaceutics! #HappyThanksgiving #Thanksgiving2024

Don’t miss our next webinar in The Precision Medicine Series, “Accelerate precision medicine uptake with impactful scientific engagement” on December 12th, 1-2pm EST/7-8pm CET. During this webinar, Ken Ruppel, VP, Scientific & Medical Services, will demonstrate the effectiveness of impactful scientific engagement in enhancing the clinical utility of precision medicine. Learn how to understand and manage the nuances of your biomarker as it launches into the open market and discover how accurate prediction of opportunities and implementation of the most cost-effective interventions can remove barriers and maximize patient identification. Register for this webinar using the link below: https://lnkd.in/ep--Jn6f #PrecisionMedicine #Webinar #BetterTestingBetterTreatment

Integrating MRD testing into solid tumor care could revolutionize oncology by offering earlier relapse detection and better treatment monitoring. Yet adoption into clinical practice remains a challenge. In this video, Dr Bob Holt, Senior Precision Medicine Strategy Advisor at Diaceutics, explores the potential of MRD in solid tumors for early relapse detection, personalized care, and faster clinical trial endpoints. How can scientific engagement help bridge gaps in precision medicine adoption? Discover more in our next webinar in the Precision Medicine Series: “Accelerate Precision Medicine Uptake with Impactful Scientific Engagement” on December 12th, 1-2pm EST / 7-8pm CET. Join Ken Ruppel, VP of Scientific & Medical Services at Diaceutics, to learn how impactful scientific engagement can drive adoption, remove barriers, and maximize patient identification. Discover strategies for launching biomarkers into the market and implementing cost-effective interventions to improve precision medicine outcomes. Register for webinar: https://lnkd.in/ep--Jn6f #MRD #PrecisionMedicine #Oncology #Webinar

Meet our team at ASH 2024! We are looking forward to attending this year’s 66th Annual Meeting of the American Society of Hematology (ASH), next month from 7-10th December in San Diego. This event brings together experts and industry leaders to discuss the latest advancements in hematology, share insights, and explore how precision medicine can drive impactful change in patient outcomes. If you’re attending, send us a message to schedule a meeting with our team! #ASH2024 #PrecisionMedicine #Hematology

Catch our latest podcast release? We were delighted to welcome guests Pr. Sophie Ferlicot, Head of the Department of Pathology of Bicêtre Hospital, AP-HP, Paris-Saclay University,?and Dr. Mario Terlizzi, a radiation oncologist and brachytherapist at the Gustave Roussy Institute for our sixth episode of the 'Better Testing, Better Treatment' podcast series. Listen as our guests draw you into a compelling discussion about the ever-evolving role of artificial intelligence in one of the most prevalent cancers! Listen now: https://lnkd.in/eWAEd3S3

Recently, we released our latest paper, “Addressing the Economic and Operational Issues of the Clinical Practice Gaps in NSCLC." This paper is an output of ‘The Precision Medicine Practice Gaps Economic, Policy, and Operational Solutions Forum’, an interdisciplinary group of precision medicine experts established in August 2023 to address the economic, policy, and operational barriers preventing 64.4% of patients from accessing optimal precision medicine treatments, as identified in Diaceutics’ widely cited Clinical Practice Gaps paper published JCO in 2022. The paper outlines five critical recommendations providing industry and policy makers with valuable and clear economic guidance and recommendations to overcome the challenges obstructing the advancement of precision medicine. ? Download Econ Paper infographic here: https://lnkd.in/e87QSujF Read more about the paper here: https://lnkd.in/e7FnGF49 #PrecisionMedicine #HealthcareInnovation #BetterTestingBetterTreatment

Last chance to register for our LabTalk today! Tune in at 8am PT/ 5pm CET to hear our experts explore the topic of clinical cases in gastrointestinal cancer. Gastrointestinal (GI) cancers are a formidable malignancy with significant morbidity and mortality rates. Symptoms are most often vague, and this makes the diagnosis more difficult. Don't miss a great session with experts Dr Beatriz Bellosillo, Mar Iglesias Coma and Dr David Schaeffer: https://lnkd.in/eZ8tEqv7

Don’t miss the next webinar in The Precision Medicine series, “Accelerate precision medicine uptake with impactful scientific engagement” on December 12th, 1-2pm EST/7-8pm CET.? ? During this webinar, Ken Ruppel, VP, Scientific & Medical Services, will demonstrate the effectiveness of impactful scientific engagement in enhancing the clinical utility of precision medicine. Learn how to understand and?manage the nuances of your biomarker as it launches into the open market and discover how accurate prediction of opportunities and implementation of the most cost-effective interventions can remove barriers and maximize patient identification. ? Register for this webinar using the link below: https://lnkd.in/ep--Jn6f ? #PrecisionMedicine #Webinar #BetterTestingBetterTreatment

There's still time to register for tomorrow's LabTalk with industry experts! "Challenging clinical cases in gastrointestinal cancer (GI): pancreatic cancer and cholangiocarcinoma" We are thrilled to welcome our guests Dr Beatriz Bellosillo, Mar Iglesias Coma and Dr David Schaeffer who will present interesting case presentations on Pancreatic cancer and Cholangiocarcinoma. Tune in for an informative session and collect your CPD credits: https://lnkd.in/e3u__nPg

This Lab Talk with Dr. Kurt Schalper explores the clinical utility of NRG1 fusions as a poor prognostic factor across tumor types, exploring NRG1+ tumors’ metastatic potential and histological features. Dr. Kurt Schalper also approached the challenges for detecting NRG1 fusions, considering that conventional methods often fail to detect these fusions. https://lnkd.in/e5599VVy??